In a survey conducted between August and September 2025, companies with annual revenue between 500 million and one billion U.S. dollars allocated ** percent of their total AI investment to research and development. Comparatively, companies with annual revenue between five and 20 billion U.S. dollars allocated ** percent.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Capgemini. (January 9, 2026). Share of AI investment allocated to R&D in biopharma as of 2025, by company size [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/1663996/ai-investment-dedicated-to-randd-by-company-size/
Capgemini. "Share of AI investment allocated to R&D in biopharma as of 2025, by company size." Chart. January 9, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/1663996/ai-investment-dedicated-to-randd-by-company-size/
Capgemini. (2026). Share of AI investment allocated to R&D in biopharma as of 2025, by company size. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/1663996/ai-investment-dedicated-to-randd-by-company-size/
Capgemini. "Share of Ai Investment Allocated to R&d in Biopharma as of 2025, by Company Size." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 9 Jan 2026, /statistics/1663996/ai-investment-dedicated-to-randd-by-company-size/
Capgemini, Share of AI investment allocated to R&D in biopharma as of 2025, by company size ÌÇÐÄÆƽâ°æ, /statistics/1663996/ai-investment-dedicated-to-randd-by-company-size/ (last visited July 28, 2026)
Share of AI investment allocated to R&D in biopharma as of 2025, by company size [Graph], Capgemini, January 9, 2026. [Online]. Available: /statistics/1663996/ai-investment-dedicated-to-randd-by-company-size/
